This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Check out creative vacation savings plan ideas to make your travel dreams come true. Effective budgeting can lead to unforgettable experiences.
19,391 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
A booming corner of lending shows signs of stress as liquidity tightens and defaults rise, with potential spillovers ...
New projections shift the timeline for potential Social Security cuts earlier, prompting retirees and savers to rethi...
Hess Midstream’s capital return program is under review as a $60 million buyback coincides with a high payout ratio a...
Oil jumped sharply in March 2026, but USOI investors faced capped upside and ongoing credit risk. The piece explains ...
Two iconic automakers face two different futures. This analysis breaks down why Ford may offer a stronger industrial ...
Trinity Capital remains a high-yield fixture in venture lending, but a balance of losses, dilution, and rate shifts u...
Circle has delivered a dramatic swing in 2024. This article breaks down the main reason it could keep climbing, the r...
Smart investing starts with the numbers. This article dissects SoFi Technologies through a valuation lens, delivering...
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Oil prices fall, stock futures rise as reports of a U.S.-backed cease-fire plan with Iran surface, setting up a cauti...